Gao, Shugeng
Chinese Academy of Medical Sciences & Peking Union Medical College · Peking University · McGill University Health Centre · Samsung Medical Center · Centre Hospitalier de l’Université de Montréal · National Cancer Center Hospital East · Kanagawa Cancer Center · Stanford Cancer Institute · Université de Montréal · Sungkyunkwan University · Stanford University
3 papers on CoChatORCID 0000-0003-4211-552X
Most cited papers
- Verified
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Wakelee, H., Liberman, M., Kato, T., Tsuboi, M., Lee, S.-H., Gao, S., Chen, K.-N., Dooms, C., Majem, M., Eigendorff, E., et al. (2023) · New England Journal of Medicine
Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 1,180
- Verified
Assessment of blood tumor mutational burden as a potential biomarker for immunotherapy in patients with non-small cell lung cancer with use of a next-generation sequencing cancer gene panel
Wang, Z., Duan, J., Cai, S., Han, M., Dong, H., Zhao, J., Zhu, B., Wang, S., Zhuo, M., Sun, J., et al. (2019) · JAMA Oncology
Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Cited by 471
- Verified · note
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
Gao, S., Li, N., Gao, S., Xue, Q., Ying, J., Wang, S., Tao, X., Zhao, J., Mao, Y., Wang, B., et al. (2020) · Journal of Thoracic Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Cited by 401
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free